Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

National Bank of Canada (NA) Stock Forecast & Price Target

→ Boost your retirement with these AI payouts (From InvestorPlace) (Ad)
Free NA Stock Alerts
C$115.66
+0.24 (+0.21%)
(As of 05/17/2024 04:00 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider Trades

National Bank of Canada Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 13 Analyst Ratings

Analysts' Consensus Price Target

C$110.50
-4.46% Downside
High ForecastC$121.00
Average ForecastC$110.50
Low ForecastC$96.00
TypeCurrent Forecast
5/21/23 to 5/20/24		1 Month Ago
4/21/23 to 4/20/24		3 Months Ago
2/20/23 to 2/20/24		1 Year Ago
5/21/22 to 5/21/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
2 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price TargetC$110.50C$108.00C$104.41C$105.32
Predicted Upside-4.46% Downside5.20% Upside6.82% Upside7.90% Upside

NA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

National Bank of Canada Stock vs. The Competition

TypeNational Bank of CanadaFinancial Services Companies
Consensus Rating Score
2.08
2.47
Consensus RatingHoldHold
News Sentiment RatingNeutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/17/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetSector PerformC$109.00 ➝ C$113.00-2.16%
5/13/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetC$113.00 ➝ C$121.00+4.72%
5/10/2024TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetC$118.00 ➝ C$121.00+4.12%
5/6/2024Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetHoldC$109.00 ➝ C$116.00+1.82%
4/5/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetC$109.00 ➝ C$121.00+7.37%
3/8/2024CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperformC$110.00 ➝ C$109.00+0.40%
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)

Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!

Click for Zack's full report
2/29/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetHoldC$107.00 ➝ C$108.00+1.94%
2/29/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetSector PerformC$105.00 ➝ C$109.00+2.89%
2/29/2024Veritas Investment Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingReduce
11/23/2023Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetMarket PerformC$101.00 ➝ C$97.00+8.03%
9/12/2023CSFB
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Set TargetOutperformC$108.00+14.71%
8/31/2023Cormark
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetMarket PerformC$109.00 ➝ C$107.00+12.75%
8/21/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		John Aiken
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost TargetUnderweightC$93.00 ➝ C$96.00-3.55%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:42 AM ET.

NA Frequently Asked Questions

What is National Bank of Canada's stock forecast and purchase recommendation?

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for National Bank of Canada is C$110.50, with a high forecast of C$121.00 and a low forecast of C$96.00. The consensus rating for National Bank of Canada stock is Hold based on the current 2 sell ratings, 8 hold ratings and 3 buy ratings for NA. Learn more on NA's analyst rating history.

Do Wall Street analysts like National Bank of Canada more than its competitors?

Analysts like National Bank of Canada less than other "financial services" companies. The consensus rating score for National Bank of Canada is 2.08 while the average consensus rating score for "financial services" companies is 2.47. Learn more on how NA compares to other companies.

Does National Bank of Canada's stock price have much upside?

According to analysts, National Bank of Canada's stock has a predicted upside of 5.29% based on their 12-month stock forecasts.

What analysts cover National Bank of Canada?

National Bank of Canada has been rated by research analysts at BMO Capital Markets, Canaccord Genuity Group, CIBC, Desjardins, Jefferies Financial Group, Royal Bank of Canada, Scotiabank, TD Securities, and Veritas Investment Research in the past 90 days.


Stock Forecasts and Research Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (TSE:NA) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
"The Biggest Drug Ever" Is Coming
Behind the Markets
4 Cryptos BETTER than Bitcoin
True Market Insiders